-
February 08, 2013
Alnylam Pharmaceuticals Inc.'s (ALNY) fourth quarter 2012 loss of $1.20 per share was narrower than the Zacks ...
-
February 05, 2013
Alnylam Pharmaceuticals Inc. (ALNY) recently entered into an exclusive global alliance with The Medicines Company ...
-
January 31, 2013
Alnylam Pharmaceuticals Inc. (ALNY) recently announced the publication of complete results from a phase I study on ...
-
January 16, 2013
Alnylam Pharmaceuticals Inc. (ALNY) provided pricing and other details regarding its recently announced public ...
-
January 15, 2013
Alnylam Pharmaceuticals Inc. (ALNY) recently began an underwritten public offering of shares of its common stock. ...
-
January 08, 2013
Alnylam Pharmaceuticals Inc (ALNY) recently announced its goal for the next two years (2013 and 2014) regarding its ...
-
December 12, 2012
The Nasdaq remains relatively unchanged, the S&P 500 has moved up 0.2% and the Dow is up 0.2% after the morning's ...
-
November 19, 2012
Alnylam Pharmaceuticals, Inc. (ALNY) and Tekmira Pharmaceuticals Corporation recently signed a new licensing ...
-
November 07, 2012
Isis Pharmaceuticals Inc. (ISIS) reported a adjusted net loss of 33 cents per share in the third quarter of 2012, ...
-
November 07, 2012
Alnylam Pharmaceuticals Inc.'s (ALNY) third quarter 2012 net loss of 38 cents per share was wider than the year-ago ...
-
October 12, 2012
Isis Pharmaceuticals, Inc. (ISIS) recently announced that it has invested $3 million in biopharma company Regulus ...
-
October 05, 2012
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, Inc. (ISIS), recently ...
-
September 19, 2012
On a good day for the market, the Nasdaq has increased 0.1%, the S&P 500 is trading up 0.2% and the Dow is up 0.3%. ...
-
September 06, 2012
Alnylam Pharmaceuticals, Inc. (ALNY) recently presented complete results from a phase IIb trial on ALN-RSV01 at the ...
-
August 29, 2012
Alnylam Pharmaceuticals, Inc. (ALNY) and Monsanto Company (MON) recently formed a strategic alliance to implement ...
-
August 28, 2012
On a bad day for the market, the Nasdaq has slipped 0.1%, the S&P 500 is trading down 0.1% and the Dow has decreased ...
-
August 22, 2012
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, Inc. (ISIS), recently ...
-
August 16, 2012
Regulus Therapeutics Inc. and Biogen Idec (BIIB) recently entered into a deal to identify microRNAs ...
-
August 07, 2012
Alnylam Pharmaceuticals Inc.'s (ALNY) second quarter 2012 net loss of 25 cents per share was narrower than the ...
-
August 07, 2012
The market is having a good day so far: the Nasdaq has climbed 0.8%; the S&P 500 is up 0.7%; and the Dow has risen ...
